<?xml version="1.0" encoding="UTF-8"?>
<p>For patients with viralâ€“bacterial infections, the availability of therapeutic options for both infectious agents is crucial. Antivirals are deployed to combat the virus, which have no effect on the bacterial pathogens (
 <xref rid="B62" ref-type="bibr">McCullers, 2011</xref>), and bacterial infections are treated with antibiotics, or such small-molecule compounds to try and prevent secondary infections. Broad-spectrum antibiotic may result in undesirable inflammatory responses in the afflicted person (
 <xref rid="B8" ref-type="bibr">Brook, 1995</xref>, 
 <xref rid="B9" ref-type="bibr">2002</xref>; 
 <xref rid="B56" ref-type="bibr">Mahar et al., 2014</xref>). To prevent complications caused by secondary bacterial infections and to eliminate bacterial pathogens, alternative antibacterial therapies are needed.
</p>
